VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,471,804 | +40.6% | 223,295 | +105.9% | 0.00% | +33.3% |
| Q2 2023 | $1,757,426 | -17.1% | 108,432 | -14.9% | 0.00% | -25.0% |
| Q1 2023 | $2,120,955 | +52.6% | 127,371 | -13.9% | 0.00% | +33.3% |
| Q4 2022 | $1,389,800 | +248.3% | 147,904 | +1.0% | 0.00% | +200.0% |
| Q3 2022 | $399,000 | -2.2% | 146,438 | +3.7% | 0.00% | 0.0% |
| Q2 2022 | $408,000 | -56.1% | 141,251 | +29.2% | 0.00% | -50.0% |
| Q1 2022 | $929,000 | +126.6% | 109,364 | +22.7% | 0.00% | +100.0% |
| Q4 2021 | $410,000 | -18.3% | 89,136 | +11.5% | 0.00% | 0.0% |
| Q3 2021 | $502,000 | +7.7% | 79,965 | +2.8% | 0.00% | 0.0% |
| Q2 2021 | $466,000 | +1.7% | 77,765 | +7.3% | 0.00% | 0.0% |
| Q1 2021 | $458,000 | +8.3% | 72,445 | -3.7% | 0.00% | 0.0% |
| Q4 2020 | $423,000 | +0.2% | 75,215 | +4.1% | 0.00% | 0.0% |
| Q3 2020 | $422,000 | -3.9% | 72,285 | +18.7% | 0.00% | 0.0% |
| Q2 2020 | $439,000 | +115.2% | 60,898 | +39.0% | 0.00% | 0.0% |
| Q1 2020 | $204,000 | – | 43,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |